The Registry of Toxic Effects of Chemical Substances
1 - Propanol, 2,3 - dibromo - , phosphate (3:1) |
UPDATE: May 2005 | MW: 697.67 | MF: C9H15Br6O4P |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | rabbit
500 mg/24 hour
|
mild
|
85JCAE -,1137,1986
|
skin | rabbit
2 mg/24 hour
|
severe
|
85JCAE -,1137,1986
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
body fluid assay
|
mouse
| Salmonella typhimurium
50 mg/kg
|
JEPTDQ 3(1-2),207,1979
|
body fluid assay
|
rat
| Salmonella typhimurium
500 mg/kg
|
CTOXAO 17,101,1980
|
cytogenetic analysis
|
hamster
lung
|
100 mg/L
|
AMONDS 3,253,1980
|
cytogenetic analysis
|
intravenous | mouse
1,500 mg/kg
|
MUREAV 60,329,1979
|
cytogenetic analysis
|
mouse
lymphocyte
|
10 mg/L
|
JEPTDQ 3(1-2),207,1979
|
DNA damage
|
human
other cell types
|
2 mg/L
|
MUREAV 56,89,1977
|
DNA damage
|
intraperitoneal | rat
2,500 nmol/L
|
CBINA8 82,195,1992
|
DNA damage
|
rat
liver
|
10 µmol/L
|
CBINA8 82,195,1992
|
DNA repair
|
Escherichia coli
|
10 µg/plate
|
MUREAV 74,107,1980
|
unscheduled DNA synthesis
|
rat
liver
|
50 µmol/L
|
MUREAV 124,213,1983
|
mutation in microorganisms
|
Escherichia coli
|
100 µg/plate (+enzymatic activation step)
|
ENMUDM 7(Suppl 5),1,1985
|
mutation in microorganisms
|
hamster
lung
|
20 µmol/L (+enzymatic activation step)
|
APTOA6 56,20,1985
|
mutation in microorganisms
|
mouse
lymphocyte
|
25 mg/L (+enzymatic activation step)
|
JEPTDQ 3(1-2),207,1979
|
mutation in microorganisms
|
Salmonella typhimurium
|
2,270 µg/plate (+enzymatic activation step)
|
MUREAV 57,381,1978
|
mutation in microorganisms
|
Salmonella typhimurium
|
110 nmol/plate (-enzymatic activation step)
|
MUTAEX 2,287,1987
|
micronucleus test
|
intraperitoneal | hamster
400 mg/kg
|
EJCODS 18,1337,1982
|
micronucleus test
|
intraperitoneal | mouse
1,020 mg/kg
|
JJIND8 66,691,1981
|
micronucleus test
|
intraperitoneal | rat
250 µmol/kg
|
CRNGDP 15,1197,1994
|
mutation in mammalian somatic cells
|
hamster
lung
|
20 µmol/L
|
MUREAV 124,213,1983
|
mutation in mammalian somatic cells
|
oral | mouse
1,200 mg/kg/4 day- continuous
|
EMMUEG 28,342,1996
|
mutation in mammalian somatic cells
|
mouse
lymphocyte
|
5 ppm
|
MUREAV 53,160,1978
|
morphological transform
|
hamster
embryo
|
25 mg/L
|
EJCODS 18,1337,1982
|
morphological transform
|
mouse
lymphocyte
|
2,500 µg/L
|
JEPTDQ 3(1-2),207,1979
|
morphological transform
|
rat
embryo
|
1,270 ng/plate
|
JJATDK 1,190,1981
|
sister chromatid exchange
|
parenteral | chicken
424 µg/kg
|
47JMAE -,137,1982
|
sister chromatid exchange
|
hamster
lung
|
5 mg/L
|
JNCIAM 60,1179,1978
|
sister chromatid exchange
|
human
embryo
|
69,700 µg/L
|
SNSHBT (20),574,1980
|
sister chromatid exchange
|
intravenous | mouse
1,500 mg/kg
|
MUREAV 60,329,1979
|
sister chromatid exchange
|
mouse
lymphocyte
|
5 mg/L
|
JEPTDQ 3(1-2),207,1979
|
sister chromatid exchange
|
mouse
lung
|
125 mg/kg
|
JNCIAM 60,1179,1978
|
sex chromosome loss and nondisjunction
|
unreported route | Drosophila melanogaster
1,000 ppm
|
JEPTDQ 3(1-2),207,1979
|
sex chromosome loss and nondisjunction
|
oral | Drosophila melanogaster
500 ppm
|
ENMUDM 1,144,1979
|
specific locus test
|
oral | Drosophila melanogaster
250 µmol/L
|
CRNGDP 15,1197,1994
|
specific locus test
|
oral | rat
12.5 gm/kg/45 day- continuous
|
EMMUEG 36,1,2000
|
sperm morphology
|
intraperitoneal | mouse
4,085 mg/kg/5 day- intermittent
|
JJIND8 66,691,1981
|
heritable translocation test
|
oral | Drosophila melanogaster
1,000 ppm/2 day- continuous
|
MUREAV 57,385,1978
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | rat
lowest published toxic dose: 8,510 mg/kg (72 day male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Paternal effects: Testes, epididymis, sperm duct
JACTDZ 5(2),153,1986
|
intraperitoneal | rat
lowest published toxic dose: 4,260 mg/kg (72 day male)
|
Reproductive: Paternal effects: Prostate, seminal vesicle, Cowper's gland, accessory glands
|
JACTDZ 5(2),153,1986
|
oral | rat
lowest published toxic dose: 1,800 mg/kg (7-15 day pregnant)
|
Reproductive: Maternal effects: Uterus, cervix, vagina
|
ESKHA5 (98),50,1980
|
oral | rat
lowest published toxic dose: 250 mg/kg (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
FCTXAV 19,67,1981
|
oral | rat
lowest published toxic dose: 450 mg/kg (7-15 day pregnant)
|
Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive)
|
JTSCDR 4,296,1979
|
oral | rat
lowest published toxic dose: 1,800 mg/kg (7-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
JTSCDR 8,339,1983
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 39 gm/kg/92 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Lung, Thorax, or Respiration: Tumors Liver: Tumors
NCITR* NCI-TR-76,1978
|
oral | mouse
toxic dose : 87 gm/kg/103 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Lung, Thorax, or Respiration: Tumors Liver: Tumors
NCITR* NCI-TR-76,1978
|
oral | mouse
toxic dose : 43 gm/kg/103 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Lung, Thorax, or Respiration: Tumors Liver: Tumors
NCITR* NCI-TR-76,1978
|
oral | rat
lowest published toxic dose: 1,330 mg/kg/76 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors
NCITR* NCI-TR-76,1978
|
oral | rat
toxic dose : 3,600 mg/kg/103 week- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors
NCITR* NCI-TR-76,1978
|
oral | rat
toxic dose : 1,800 mg/kg/103 week- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors
NCITR* NCI-TR-76,1978
|
oral | rat
toxic dose : 1,820 mg/kg/2 year- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Kidney, Ureter, and Bladder: Bladder tumors
FCTXAV 18,743,1980
|
oral | rat
toxic dose : 43,680 mg/kg/2 year- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Kidney, Ureter, and Bladder: Bladder tumors
FCTXAV 18,743,1980
|
oral | rat
toxic dose : 26 gm/kg/52 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Gastrointestinal: Colon tumors Nutritional and Gross Metabolic: Weight loss or decreased weight gain
LAINAW 44,74,1981
|
skin | mouse
lowest published toxic dose: 85 gm/kg/71 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Lung, Thorax, or Respiration: Tumors Gastrointestinal: Tumors
CNREA8 38,3236,1978
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lethal dose (50 percent kill): 300 mg/kg
|
N/R
|
NTIS** AD277-689
|
oral | mouse
lethal dose (50 percent kill): 6,800 mg/kg
|
Behavioral: Excitement
|
GTPZAB 29(12),53,1985
|
oral | rat
lethal dose (50 percent kill): 810 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Liver: Other changes
SRTCAC 36(1-4),10,1989
|
skin | rabbit
lethal dose (50 percent kill): >8 gm/kg
|
N/R
|
FRCHD6 1,205,1974
|
unreported route | mouse
lethal dose (50 percent kill): 1,149 mg/kg
|
N/R
|
JJIND8 66,691,1981
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | rat
lowest published toxic dose: 1,400 mg/kg/7 day- intermittent
|
Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) | Kidney, Ureter, and Bladder: Other changes in urine composition
JJATDK 7,23,1987
|
skin | rabbit
lowest published toxic dose: 29,510 mg/kg/13 week- intermittent
|
Liver: Changes in liver weight | Related to Chronic Data: Changes in testicular weight
JTEHD6 3,979,1977
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 20,575,1979
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 71,905,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMSUDL 7,369,1987
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 71,905,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 2A
|
IMEMDT 71,905,1999
|
TOXICOLOGY REVIEW
|
|
ENVRAL 13,74,1977
|
TOXICOLOGY REVIEW
|
|
CTOXAO 17,101,1980
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - FINLAND
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - FRANCE
|
Carcinogen, JAN1993
|
Occupational Exposure Limit - SWEDEN
|
Carcinogen, JAN1999
|
|
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: M1916; |
Number of Industries 2; Total Number of Facilities 18; Number of Occupations 7; Total Number of Employees Exposed 206 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat
|
EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation
|
EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay; Histidine reversion-Ames test
|
EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-mouse; D melanogaster Sex-linked lethal
|
EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-nonhuman; In vivo SCE-nonhuman
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as a flame retardant additive for synthetic textiles and plastics
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NCI Carcinogenesis Bioassay (feed);clear evidence:mouse,rat
|
NCITR* NCI-TR-76,1978
|
NTP 11th Report on Carcinogens,2004:Reasonably anticipated to be a human carcinogen
|
|
REFERENCES:
CODEN
|
|
REFERENCE
47JMAE
|
"Cytogenetic Assays of Environmental Mutagens," Hsu, T.C., ed., Totowa, NJ, Allanheld, Osmun
& Co., 1982
|
85JCAE
|
"Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J., Prague, Czechoslovakia,
Avicenum, 1986
|
AMONDS
|
Applied Methods in Oncology. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York,
NY 10017) V.1- 1978-
|
APTOA6
|
Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher
information, see PHTOEH
|
CBINA8
|
Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1969-
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
CRNGDP
|
Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford
OX8 1JJ, UK) V.1- 1980-
|
CTOXAO
|
Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW.
|
EJCODS
|
European Journal of Cancer and Clinical Oncology. (Pergamon Press, c/o Elsevier Science, 660
White Plains Rd., Tarrytown, NY 10591) V.17(7)- 25, 1981-89. For publisher information, see
EJCAEL
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
ENMUDM
|
Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see
EMMUEG.
|
ENVRAL
|
Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-
1967-
|
ESKHA5
|
Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei
Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886-
|
FCTXAV
|
Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see
FCTOD7.
|
FRCHD6
|
JFF/Fire Retardant Chemistry. (Technomic Pub. Co., Inc., 265 W. State St., Westport, CN
06880) V.1- 1974-
|
GTPZAB
|
Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see
MTPEEI
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
IMSUDL
|
IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY
12210) No.1- 1979-
|
JACTDZ
|
Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New
York, NY 10128) V.1-12, 1982-1993. Discontinued.
|
JEPTDQ
|
Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3),
1977-81(?). For publisher information, see JEPOEC.
|
JJATDK
|
JAT, Journal of Applied Toxicology. (John Wiley & Sons Ltd., Baffins Lane, Chichester, W.
Sussex PO19 1UD, UK) V.1- 1981-
|
JJIND8
|
JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For
publisher information, see JNCIEQ.
|
JNCIAM
|
Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher
information, see JJIND8.
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
JTSCDR
|
Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor,
Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976-
|
LAINAW
|
Laboratory Investigation. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202)
V.1- 1952-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
MUTAEX
|
Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ,
UK) V.1- 1986-
|
NCITR*
|
National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205.
For publisher information, see NTPTR*.
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
SNSHBT
|
Senshokutai. Chromosome. (Sensyokutai Gakkai, Kaokusai Kirisutokyo Daigaku, Mitaka,
Tokyo-to, Japan) No.1- 1946- Adopted new numbering in 1976.
|
SRTCAC
|
Science Reports of the Research Institutes, Tohoku University, Series C: Medicine. (Tohoku
University, Research Institute for Tuberculosis and Cancer, 4-1 Seiryo-machi, Sendai, Japan)
V.1- 1949-
|
|